These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14873548)

  • 21. Fatal pancytopenia following the use of mesantoin; report of a case.
    WELLER RW; METCALFE J
    N Engl J Med; 1949 Jul; 241(1):17. PubMed ID: 18135085
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mesantoin reaction simulating infection].
    JONSSON M
    Nord Med; 1961 Mar; 65():408-11. PubMed ID: 13790648
    [No Abstract]   [Full Text] [Related]  

  • 23. [Manifestations of intoxication in mesantoin therapy of epilepsy].
    GABRIELSEN LH
    Tidsskr Nor Laegeforen; 1950 Oct; 70(19):618-9. PubMed ID: 14788014
    [No Abstract]   [Full Text] [Related]  

  • 24. Aplastic anaemia due to 3-methyl-5-phenyl-5-ethyl-hydantoin ("mesantoin").
    WILLIAMS CM
    Clin Rep; 1960; 10():69-71. PubMed ID: 13785405
    [No Abstract]   [Full Text] [Related]  

  • 25. Mesantoin in difficult cases of epilepsy.
    HOUFEK EE; HERMANN HT
    Nebr State Med J; 1951 Jul; 36(7):234-6. PubMed ID: 14852996
    [No Abstract]   [Full Text] [Related]  

  • 26. Mesantoin in epilepsy; report of 80 cases.
    BERCEL NA; FINESILVER B; SOLOMON P; SOMERFELD-ZISKIND E; ZISKIND E
    J Am Med Assoc; 1950 Aug; 143(17):1460-2. PubMed ID: 15428293
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hydantal and mesantoin in treatment of epilepsy].
    SOLMS W; WALLENTIN G
    Wien Klin Wochenschr; 1950 Aug; 62(34):588-91. PubMed ID: 14776993
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of epilepsy with mesantoin or hydantal.
    BRICK H
    Va Med Mon (1918); 1951 Aug; 78(8):423-9. PubMed ID: 14855998
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical evaluation of mesantoin in treatment of epilepsy.
    MALLIN AW; GAMMON GD
    AMA Arch Neurol Psychiatry; 1951 Jan; 65(1):128-9. PubMed ID: 14782786
    [No Abstract]   [Full Text] [Related]  

  • 30. [Case of generalized lymphadenopathy with high fever, diffuse dermal eruptions, eosinophilia and plasmocytosis due to the administration of an anticonvulsant (mesantoin)].
    AKSOY M; DEVRIMEL H; ALPUSTUN H
    Turk Tip Cemiy Mecm; 1959 May; 25():273-9. PubMed ID: 13792274
    [No Abstract]   [Full Text] [Related]  

  • 31. [Toxic effects of mesantoin].
    HOLUB K; WILD H
    Wien Klin Wochenschr; 1950 Dec; 62(51):954-6. PubMed ID: 14828743
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experiences with hydantal Sandoz and Mesantoin in the therapy of epilepsy of children].
    SCHMUTTERMEIER E; STACHEL I
    Osterr Z Kinderheilkd Kinderfuersorge; 1952 Jan; 7(1-2):133-47. PubMed ID: 14948161
    [No Abstract]   [Full Text] [Related]  

  • 33. [Another case of importance bone-marrow lesion by mesantoin].
    WEINMANN O
    Wien Klin Wochenschr; 1951 Feb; 63(7):139. PubMed ID: 14836617
    [No Abstract]   [Full Text] [Related]  

  • 34. [New antiepileptic; 3-methyl-5,5-phenylethyl-hydantoin. (mesantoin Sandoz)].
    SCHERGNA E
    Rass Int Clin Ter; 1951 Feb; 31(4):101-10. PubMed ID: 14844726
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative results in seizure control using phenobarbital, dilantin, and mesantoin.
    RUSKIN DB
    Am J Psychiatry; 1950 Dec; 107(6):415-21. PubMed ID: 14838144
    [No Abstract]   [Full Text] [Related]  

  • 36. Mesantoin in the management of the hospitalized psychotic epileptic; report of toxic effects and one fatality.
    HOFSTATTER L
    South Med J; 1951 Sep; 44(9):827-32. PubMed ID: 14866529
    [No Abstract]   [Full Text] [Related]  

  • 37. [Aplastic anemia caused by the hydantoin derivative mesantoin; fatal case].
    STOUSLAND H
    Tidsskr Nor Laegeforen; 1951 Jul; 71(13-14):428-9. PubMed ID: 14855463
    [No Abstract]   [Full Text] [Related]  

  • 38. [DATA TO THE PROBLEM OF CHRONIC MESANTOIN POISONING].
    GRIESSHABER W
    Med Klin; 1964 Jun; 59():932-4. PubMed ID: 14234232
    [No Abstract]   [Full Text] [Related]  

  • 39. Generalized lymphadenopathy and nephrotic syndrome as a manifestation of mephenytoin (mesantoin) toxicity.
    Snead C; Siegel N; Hayslett J
    Pediatrics; 1976 Jan; 57(1):98-101. PubMed ID: 1246508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MESANTOIN LYMPHADENOPATHY MORPHOLOGICALLY SIMULATING HODGKIN'S DISEASE.
    DOYLE AP; HELLSTROM HR
    Ann Intern Med; 1963 Sep; 59():363-8. PubMed ID: 14065954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.